- Home
- PRME vs BLW Comparison
PRME vs BLW Comparison
Compare PRME & BLW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PRME
- BLW
- Stock Information
- Founded
- PRME 2019
- BLW 2003
- Country
- PRME United States
- BLW United States
- Employees
- PRME N/A
- BLW N/A
- Industry
- PRME Medicinal Chemicals and Botanical Products
- BLW Other Consumer Services
- Sector
- PRME Health Care
- BLW Consumer Discretionary
- Exchange
- PRME Nasdaq
- BLW Nasdaq
- Market Cap
- PRME 624.0M
- BLW 543.0M
- IPO Year
- PRME 2022
- BLW N/A
- Fundamental
- Price
- PRME $3.72
- BLW $14.18
- Analyst Decision
- PRME Buy
- BLW
- Analyst Count
- PRME 6
- BLW 0
- Target Price
- PRME $8.88
- BLW N/A
- AVG Volume (30 Days)
- PRME 3.0M
- BLW 85.9K
- Earning Date
- PRME 08-07-2025
- BLW 01-01-0001
- Dividend Yield
- PRME N/A
- BLW 8.83%
- EPS Growth
- PRME N/A
- BLW N/A
- EPS
- PRME N/A
- BLW 1.81
- Revenue
- PRME $4,961,000.00
- BLW N/A
- Revenue This Year
- PRME $179.58
- BLW N/A
- Revenue Next Year
- PRME N/A
- BLW N/A
- P/E Ratio
- PRME N/A
- BLW $7.73
- Revenue Growth
- PRME 739.42
- BLW N/A
- 52 Week Low
- PRME $1.11
- BLW $12.35
- 52 Week High
- PRME $5.17
- BLW $14.26
- Technical
- Relative Strength Index (RSI)
- PRME 54.32
- BLW 54.99
- Support Level
- PRME $3.09
- BLW $14.09
- Resistance Level
- PRME $3.49
- BLW $14.20
- Average True Range (ATR)
- PRME 0.25
- BLW 0.08
- MACD
- PRME 0.01
- BLW 0.01
- Stochastic Oscillator
- PRME 95.49
- BLW 66.67
About PRME Prime Medicine Inc.
Prime Medicine Inc is a biotechnology company committed to delivering genetic therapies to address diseases by deploying gene editing technology, Prime Editing. The Prime Editing technology is a next-generation technology that can search and replace to restore normal genetic function in the genome and can treat a wide spectrum of diseases with high unmet medical needs and efficient and broad gene editing technology.
About BLW Blackrock Limited Duration Income Trust
Blackrock Ltd Duration Income Trust is a diversified investment fund with an investment objective to provide current income and capital appreciation. The Fund's portfolio normally has an average portfolio duration of less than five years. The Fund may invest directly in such securities or synthetically through the use of derivatives.